Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E5 oncogene protein is a small, hydrophobic transmembrane protein encoded by papillomaviruses. It promotes cell transformation, modulates growth factor receptor signaling (PDGFβR, EGFR), and impairs immune recognition. While critical in early stages of viral infection and tumorigenesis, it is often lost in advanced cancers, potentially limiting its therapeutic utility.
Modulates signal transduction pathways through interactions with key cellular proteins involved in growth regulation. Activates PDGFβR (BPV1) or enhances EGFR signaling by inhibiting its degradation (HPV16). Downregulates MHC class I expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E5 Oncogene Protein (E5).